Abordaje multidisciplinar del síndrome de abstinencia grave a ácido gamma-hidroxibutírico y 3-metilmetcatinona
Authors:
- Sandra Molins PascualSPSandra Molins Pascual
- Regino SerranoRSRegino Serrano
- Lorena IbarguchiLILorena Ibarguchi
- Helen Dolengevich SegalHSHelen Dolengevich Segal
Open Access
- 1 January 2019
- journal article
- Published by Elsevier in Medicina Clínica Práctica
- Vol. 2 (1) , 1-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacological profile of mephedrone analogs and related new psychoactive substancesNeuropharmacology, 2018
- Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 StudyAIDS Patient Care and STDs, 2018
- Treatment consumption and treatment re-enrollment in GHB-dependent patients in The NetherlandsDrug and Alcohol Dependence, 2017
- Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse PreventionCNS Drugs, 2016
- “Chemsex” and harm reduction need among gay men in South LondonInternational Journal of Drug Policy, 2015
- What is chemsex and why does it matter?BMJ, 2015
- Seven Days of Gamma-Hydroxybutyrate (GHB) Use Produces Severe WithdrawalAnnals of Emergency Medicine, 2006